Literature DB >> 17242991

Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension.

Nicola Calandrella1, Gianfranco Scarsella, Nicola Pescosolido, Gianfranco Risuleo.   

Abstract

Ocular hypertension is a symptom of a glaucomatous condition characterized by a severe vision decrease. Blindness caused by the apoptotic death of the retinal ganglion cells and of the astrocytes of the optic nerve may eventually result. Experimental hypertension was induced by inoculation of methylcellulose in the anterior chamber. Chromatin staining, TUNEL assay, and inter-nucleosomal DNA fragmentation observed in retina and optic nerve strongly suggest that hypertension causes apoptosis. Immunolocalization of the fibrillary acidic glial protein, specific of cell stress, and caspase-3 in the same tissues, further support this mode of cell death. Activation of the ubiquitin dependent proteolytic system was also observed. Protection from apoptosis exerted by administration of the peroxide scavenger trolox, suggests that the apoptotic pathway is activated by an oxidative stress. The data presented here show that the experimental hypertensive insult induces degenerative and apoptotic events comparable to those observed in human glaucoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242991     DOI: 10.1007/s11010-006-9407-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  45 in total

1.  In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head.

Authors:  G Tezel; M R Hernandez; M B Wax
Journal:  Glia       Date:  2001-05       Impact factor: 7.452

Review 2.  Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function.

Authors:  G Raivich; M Bohatschek; C U Kloss; A Werner; L L Jones; G W Kreutzberg
Journal:  Brain Res Brain Res Rev       Date:  1999-07

Review 3.  Reappraisal of the mechanisms of glaucomatous optic nerve damage.

Authors:  H A Quigley
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

Review 4.  Astrocyte responses to CNS injury.

Authors:  M D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

Review 5.  Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.

Authors:  A H Neufeld
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

6.  Phenotypic variation of retinal pigment epithelium in age-related macular degeneration.

Authors:  Clyde Guidry; Nancy E Medeiros; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

7.  Trolox inhibits apoptosis in irradiated MOLT-4 lymphocytes.

Authors:  D E McClain; J F Kalinich; N Ramakrishnan
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

8.  Glial fibrillary acidic protein increases in Müller cells after retinal detachment.

Authors:  P A Erickson; S K Fisher; C J Guérin; D H Anderson; D D Kaska
Journal:  Exp Eye Res       Date:  1987-01       Impact factor: 3.467

9.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

10.  Heterogeneity of astrocytes in human optic nerve head.

Authors:  H Ye; M R Hernandez
Journal:  J Comp Neurol       Date:  1995-11-27       Impact factor: 3.215

View more
  10 in total

Review 1.  Mechanisms of retinal ganglion cell injury and defense in glaucoma.

Authors:  Juan Qu; Danyi Wang; Cynthia L Grosskreutz
Journal:  Exp Eye Res       Date:  2010-04-13       Impact factor: 3.467

Review 2.  Mitochondrial dysfunction in retinal diseases.

Authors:  Megha Barot; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Curr Eye Res       Date:  2011-10-06       Impact factor: 2.424

Review 3.  The ubiquitin-proteasome system in retinal health and disease.

Authors:  Laura Campello; Julián Esteve-Rudd; Nicolás Cuenca; José Martín-Nieto
Journal:  Mol Neurobiol       Date:  2013-01-22       Impact factor: 5.590

4.  Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma.

Authors:  N Calandrella; C De Seta; G Scarsella; G Risuleo
Journal:  Cell Death Dis       Date:  2010-08-05       Impact factor: 8.469

Review 5.  The cell stress machinery and retinal degeneration.

Authors:  Dimitra Athanasiou; Monica Aguilà; Dalila Bevilacqua; Sergey S Novoselov; David A Parfitt; Michael E Cheetham
Journal:  FEBS Lett       Date:  2013-05-15       Impact factor: 4.124

6.  Degenerative effects in rat eyes after experimental ocular hypertension.

Authors:  G Scarsella; M Nebbioso; S Stefanini; N Pescosolido
Journal:  Eur J Histochem       Date:  2012-10-08       Impact factor: 3.188

7.  Mitochondrial genome analysis of primary open angle glaucoma patients.

Authors:  Deblina Banerjee; Antara Banerjee; Suddhasil Mookherjee; Mansi Vishal; Arijit Mukhopadhyay; Abhijit Sen; Analabha Basu; Kunal Ray
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Cellular stress response, redox status, and vitagenes in glaucoma: a systemic oxidant disorder linked to Alzheimer's disease.

Authors:  Angela Trovato Salinaro; Carolin Cornelius; Guido Koverech; Angela Koverech; Maria Scuto; Francesca Lodato; Vincenzo Fronte; Vera Muccilli; Michele Reibaldi; Antonio Longo; Maurizio G Uva; Vittorio Calabrese
Journal:  Front Pharmacol       Date:  2014-06-06       Impact factor: 5.810

9.  Differential cytotoxicity of MEX: a component of Neem oil whose action is exerted at the cell membrane level.

Authors:  Francesca Ricci; Valerio Berardi; Gianfranco Risuleo
Journal:  Molecules       Date:  2008-12-31       Impact factor: 4.411

Review 10.  Strategies to Reduce Oxidative Stress in Glaucoma Patients.

Authors:  Maria D Pinazo-Duran; Kian Shoaie-Nia; Vicente Zanon-Moreno; Silva M Sanz-Gonzalez; Javier Benitez Del Castillo; Jose J Garcia-Medina
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.